Growth Metrics

Humana (HUM) Cost of Revenue (2016 - 2025)

Humana has reported Cost of Revenue over the past 17 years, most recently at $28.7 billion for Q4 2025.

  • Quarterly results put Cost of Revenue at $28.7 billion for Q4 2025, up 13.16% from a year ago — trailing twelve months through Dec 2025 was $110.8 billion (up 10.08% YoY), and the annual figure for FY2025 was $110.8 billion, up 10.08%.
  • Cost of Revenue for Q4 2025 was $28.7 billion at Humana, up from $28.0 billion in the prior quarter.
  • Over the last five years, Cost of Revenue for HUM hit a ceiling of $28.7 billion in Q4 2025 and a floor of $17.1 billion in Q2 2021.
  • Median Cost of Revenue over the past 5 years was $21.9 billion (2023), compared with a mean of $22.2 billion.
  • Biggest five-year swings in Cost of Revenue: increased 22.6% in 2023 and later rose 5.62% in 2025.
  • Humana's Cost of Revenue stood at $17.4 billion in 2021, then increased by 6.56% to $18.6 billion in 2022, then grew by 22.6% to $22.8 billion in 2023, then increased by 11.41% to $25.4 billion in 2024, then rose by 13.16% to $28.7 billion in 2025.
  • The last three reported values for Cost of Revenue were $28.7 billion (Q4 2025), $28.0 billion (Q3 2025), and $27.6 billion (Q2 2025) per Business Quant data.